Department of Medical Biochemistry, Molecular Biology and Immunology, School of Medicine, University of Seville, 41009 Seville, Spain.
Department of Medicine, School of Medicine, University of Seville, 41009 Seville, Spain; 4Medical Oncology Service, Virgen Macarena University Hospital, 41009 Seville, Spain.
Int J Mol Med. 2025 Jan;55(1). doi: 10.3892/ijmm.2024.5444. Epub 2024 Oct 25.
Src‑associated in mitosis 68 kDa protein (Sam68) is a protein encoded by the heteronuclear ribonucleoprotein particle K homology (KH) single domain‑containing, RNA‑binding, signal transduction‑associated protein 1 (known as ) gene in humans. This protein contains binding sites for critical components in a variety of cellular processes, including the regulation of gene expression, RNA processing and cell signaling. Thus, Sam68 may play a role in a variety of diseases, including cancer. Sam68 has been widely demonstrated to participate in tumor cell proliferation, progression and metastasis to be involved in the regulation of cancer stem cell self‑renewal. Based on the body of evidence available, Sam68 emerges as a promising target for this disease. The objectives of the present included summarizing the role of Sam68 in cancer murine models and cancer patients, unraveling the molecular mechanisms underlying its oncogenic potential and discussing the effectiveness of antitumor agents in reducing the malignant effects of Sam68 during tumorigenesis.
Src 相关蛋白激酶 68 千道尔顿(Sam68)是一种由异核核糖核蛋白颗粒 K 同源(KH)单结构域包含、RNA 结合、信号转导相关蛋白 1(称为)基因编码的蛋白质。该蛋白质包含在多种细胞过程中的关键成分的结合位点,包括基因表达、RNA 加工和细胞信号转导的调节。因此,Sam68 可能在多种疾病中发挥作用,包括癌症。Sam68 已被广泛证明参与肿瘤细胞的增殖、进展和转移,参与调节癌症干细胞的自我更新。基于现有证据,Sam68 作为该疾病的一个有前途的靶点出现。本研究的目的包括总结 Sam68 在癌症小鼠模型和癌症患者中的作用,揭示其致癌潜能的分子机制,并讨论抗肿瘤药物在减少肿瘤发生过程中 Sam68 恶性影响的有效性。